BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 19389465)

  • 1. The ovine urokinase plasminogen activator and its receptor cDNAs: molecular cloning, characterization and expression in various tissues.
    Theodorou G; Bizelis I; Rogdakis E; Politis I
    Gene; 2009 Aug; 443(1-2):158-69. PubMed ID: 19389465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ovine plasminogen activator inhibitors type 1 and type 2 cDNAs: molecular cloning, characterization and expression in various tissues.
    Theodorou G; Bizelis I; Rogdakis E; Politis I
    Gene; 2010 Apr; 454(1-2):20-30. PubMed ID: 20114071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of human single chain urokinase to Chinese Hamster Ovary cells and cloning of hamster u-PAR.
    Fowler B; Mackman N; Parmer RJ; Miles LA
    Thromb Haemost; 1998 Jul; 80(1):148-54. PubMed ID: 9684801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cloning of the 5' regulatory regions and functional characterization of the core promoters of ovine PLAU (u-PA) and SERPIN1 (PAI-1).
    Lampidonis AD; Theodorou G; Pecorini C; Rebucci R; Baldi A; Politis I
    Gene; 2011 Dec; 489(1):11-20. PubMed ID: 21914465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of urokinase-type plasminogen activator (u-PA), u-PA receptor, and tissue-type PA messenger RNAs in human hepatocellular carcinoma.
    De Petro G; Tavian D; Copeta A; Portolani N; Giulini SM; Barlati S
    Cancer Res; 1998 May; 58(10):2234-9. PubMed ID: 9605771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute mastitis induces upregulation of expression of plasminogen activator-related genes by blood monocytes and neutrophils in dairy ewes.
    Theodorou G; Daskalopoulou M; Chronopoulou R; Baldi A; Dell'orto V; Politis I
    Vet Immunol Immunopathol; 2010 Nov; 138(1-2):124-8. PubMed ID: 20800291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study of the effect of TF/FVIIa complex on the expression of u-PAR mRNA in human ovarian cancer].
    Fang J; Wei WN; Xia LH; Song SJ
    Zhonghua Xue Ye Xue Za Zhi; 2004 Mar; 25(3):143-6. PubMed ID: 15182581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo and in vitro expression of the plasminogen activators and urokinase type plasminogen activator receptor (u-PAR) in the pig oviduct.
    Roldán-Olarte M; García DC; Jiménez-Díaz M; Valdecantos PA; Miceli DC
    Anim Reprod Sci; 2012 Dec; 136(1-2):90-9. PubMed ID: 23103014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The urokinase-type plasminogen activator, its receptor and u-PA inhibitor type-1 affect in vitro growth and invasion of Kaposi's sarcoma and capillary endothelial cells: role of HIV-Tat protein.
    Margheri F; D'Alessio S; Serratì S; Pucci M; Del Rosso A; Benelli R; Ferrari N; Noonan DM; Albini A; Fibbi G; Del Rosso M
    Int J Oncol; 2005 Jul; 27(1):223-35. PubMed ID: 15942664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression and significance of urokinase-type plasminogen activator, its receptor, and type 2 inhibitor in giant cell tumor of bone].
    Li H; Dong S; Zeng Y
    Zhonghua Zhong Liu Za Zhi; 2001 Sep; 23(5):386-8. PubMed ID: 11810768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stable expression of antisense urokinase mRNA inhibits the proliferation and invasion of human hepatocellular carcinoma cells.
    Tavian D; Salvi A; De Petro G; Barlati S
    Cancer Gene Ther; 2003 Feb; 10(2):112-20. PubMed ID: 12536199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functions of the fibrinolytic system in human Ito cells and its control by basic fibroblast and platelet-derived growth factor.
    Fibbi G; Pucci M; Grappone C; Pellegrini G; Salzano R; Casini A; Milani S; Del Rosso M
    Hepatology; 1999 Mar; 29(3):868-78. PubMed ID: 10051491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased urokinase receptor levels in human gastrointestinal neoplasia and related liver metastases.
    Sier CF; Quax PH; Vloedgraven HJ; Verheijen JH; Griffioen G; Ganesh S; Lamers CB; Verspaget HW
    Invasion Metastasis; 1993; 13(6):277-88. PubMed ID: 7860221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cloning and functional characterization of the ovine Hormone Sensitive Lipase (HSL) full-length cDNAs: an integrated approach.
    Lampidonis AD; Argyrokastritis A; Stravopodis DJ; Voutsinas GE; Ntouroupi TG; Margaritis LH; Bizelis I; Rogdakis E
    Gene; 2008 Jun; 416(1-2):30-43. PubMed ID: 18436396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteolytic cleavage of urokinase-type plasminogen activator by stromelysin-1 (MMP-3).
    Ugwu F; Van Hoef B; Bini A; Collen D; Lijnen HR
    Biochemistry; 1998 May; 37(20):7231-6. PubMed ID: 9585535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Escherichia coli lipopolysaccharide on u-PA activity and u-PA and u-PAR RNA expression in a bovine mammary epithelial cell line.
    Baldi A; Pecorini C; Rebucci R; Saccone F; Cheli F; Miranda-Ribera A; Lecchi C; Ceciliani F
    Res Vet Sci; 2012 Oct; 93(2):758-62. PubMed ID: 22103977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urokinase (u-PA) is produced by collecting duct principal cells and is post-transcriptionally regulated by SV40 large-T, arginine vasopressin, and epidermal growth factor.
    Piedagnel R; Tiger Y; Lelongt B; Ronco PM
    J Cell Physiol; 2006 Feb; 206(2):394-401. PubMed ID: 16155905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of plasminogen activator-related genes in the adipose tissue of lactating dairy sheep in the early post-weaning period.
    Theodorou G; Lampidonis AD; Laliotis GP; Bizelis I; Politis I
    J Anim Physiol Anim Nutr (Berl); 2012 Jun; 96(3):403-7. PubMed ID: 21561489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and characterization of recombinant porcine plasminogen activator inhibitor-1.
    Bijnens AP; Knockaert I; Cousin E; Kruithof EK; Declerck PJ
    Thromb Haemost; 1997 Feb; 77(2):350-6. PubMed ID: 9157595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth inhibition of vascular smooth muscle cells derived from urokinase receptor (u-PAR)-deficient mice in the presence of carcinoma cells.
    Ueshima S; Fukao H; Okada K; Matsuo O
    Thromb Res; 2004; 113(1):41-9. PubMed ID: 15081564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.